StockData
Ocean Biomedical, Inc. logo

Ocean Biomedical, Inc. (OCEA) stock

OCEAOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2025, quý kết thúc ngày Mar 31, 2025Last filing: 10-Q on May 15, 2025
$0.00−0.00 (-16.67%)

Close on Oct 19, 2026Market cap $45.51KP/E –Yield –

Ocean Biomedical r&d expenses

Research and development expenses are spending on new products and technology.

Ocean Biomedical's R&D Expenses for the twelve months ending Mar 31, 2025 was $18.00K. For fiscal 2024 it was $26.00K, down 96.3% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2024Dec 31, 2024$26.00K-96.3%
FY2023Dec 31, 2023$709.00K-91.6%
FY2022Dec 31, 2022$8.41M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2025Mar 31, 2025$18.00K-30.8%
Q4 FY2024Dec 31, 2024$0-100.0%
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$0-100.0%
Q1 FY2024Mar 31, 2024$26.00K-83.9%
Q3 FY2023Sep 30, 2023$305.00K-83.6%
Q2 FY2023Jun 30, 2023$28.00K-99.1%
Q1 FY2023Mar 31, 2023$393.00K-87.7%
Q4 FY2022Dec 31, 2022$161.00K–
Q3 FY2022Sep 30, 2022$1.86M–
Q2 FY2022Jun 30, 2022$3.19M–
Q1 FY2022Mar 31, 2022$3.20M–

More Ocean Biomedical figures

See a number that looks wrong?